Singular Genomics Systems, Inc. (OMIC) News
Filter OMIC News Items
OMIC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest OMIC News From Around the Web
Below are the latest news stories about SINGULAR GENOMICS SYSTEMS INC that investors may wish to consider to help them evaluate OMIC as an investment opportunity.
Singular Genomics Systems Founder Acquires 4.6% More StockEven if it's not a huge purchase, we think it was good to see that Eli Glezer, the Founder of Singular Genomics... |
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call TranscriptSingular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript November 14, 2023 Singular Genomics Systems, Inc. beats earnings expectations. Reported EPS is $-0.31, expectations were $-0.38. Operator: Greetings. Welcome to the Singular Genomics Systems, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Philip […] |
Q3 2023 Singular Genomics Systems Inc Earnings CallQ3 2023 Singular Genomics Systems Inc Earnings Call |
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial ResultsSAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023. “We shipped five G4 systems in the third quarter, our highest quarterly total yet, launched Max Read flow cell kits for single cell sequencing, and saw o |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning! |
Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the third quarter 2023 after the market close on Tuesday, November 14, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investor |
Beware! 3 Biotech Stocks Waving Massive Red Flags Right NowThere are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of. |
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company ShowcaseSAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to participate in the virtual Gilmartin Group Emerging Growth Company Showcase. Singular Genomics’ management is scheduled to present on Thursday, September 21, 2023, at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time. Investors and other interested partie |
Q2 2023 Singular Genomics Systems Inc Earnings CallQ2 2023 Singular Genomics Systems Inc Earnings Call |
Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial ResultsSAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the second quarter ended June 30, 2023. “We made significant advancements across our operations, manufacturing and commercial infrastructure, and saw growth in our sales funnel. In addition, we shi |